Vazirani Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Vazirani Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,000	Closed	-$2.04M	–	43
2022 Q3	$2.04M	Buy	+30,000	New	+$1.65M	2.19%	17

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vazirani Asset Management's GBT Position: Q4 2022 in Review

Vazirani Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 30,000 shares — an estimated $2.04M sold.

Vazirani Asset Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $2.04M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Vazirani Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Vazirani Asset Management sold 30,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2.04M.
Vazirani Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Vazirani Asset Management's Global Blood Therapeutics, Inc. position peaked at $2.04M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Vazirani Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.